Caribou Biosciences (CRBU) Cash from Investing Activities (QoQ) (2020 - 2026)
Caribou Biosciences (CRBU) Cash from Investing Activities (QoQ) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Caribou Biosciences |
156.73 Mn |
39.11 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
33.47% |
| Dec 31, 2025 |
65.61% |
| Sep 30, 2025 |
-54.86% |
| Jun 30, 2025 |
-51.33% |
| Mar 31, 2025 |
209.99% |
| Dec 31, 2024 |
-39.93% |
| Sep 30, 2024 |
25.10% |
| Jun 30, 2024 |
-7.65% |
| Mar 31, 2024 |
172.94% |
| Dec 31, 2023 |
54.04% |
| Sep 30, 2023 |
-718.91% |
| Jun 30, 2023 |
-46.56% |
| Mar 31, 2023 |
1,669.49% |
| Dec 31, 2022 |
114.03% |
| Sep 30, 2022 |
40.32% |
| Jun 30, 2022 |
80.62% |
| Mar 31, 2022 |
58.55% |
| Dec 31, 2021 |
-8,913.52% |
| Sep 30, 2021 |
-298.76% |
| Jun 30, 2021 |
-2,100.00% |
